Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

August 14, 2020
Open Access

FOXK1 Participates in DNA Damage Response by Controlling 53BP1 Function

Cell Reports
Mengfan TangJunjie Chen
August 5, 2020

BRCA1 mutations in cancer: coordinating deficiencies in homologous recombination with tumorigenesis

Cancer Research
John J Krais, Neil Johnson
August 11, 2020
Review

Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features

Breast Care
Mercedes Herrera JuarezEva Ciruelos Gil
August 6, 2020

Niraparib maintenance in frontline management of ovarian cancer: a cost effectiveness analysis

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
David A BarringtonDavid E Cohn
August 14, 2020

BRCA sequencing of tumors: understanding its implications in the oncology community

Chinese Clinical Oncology
Rachel Su Jen Wong, Soo-Chin Lee
August 8, 2020
Open Access

AtNBR1 is a selective autophagic receptor for AtExo70E2 in Arabidopsis

Plant Physiology
Chang-Yang JiLiwen Jiang
August 10, 2020

Pinning Pink: Messages About Hereditary Breast Cancer Risk on Pinterest

Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
Carrie A MillerBernard F Fuemmeler
August 8, 2020

BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Sabrina PiedimonteXing Zeng
August 9, 2020
Open Access

Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer

Frontiers in Oncology
Ulyana A BoyarskikhMaxim Leonidovich Filipenko
August 2, 2020

BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma

Biochemical and Biophysical Research Communications
Fang WangXiangrui Ma
August 14, 2020

PARP Inhibitors & Prostate Cancer: To Infinity and Beyond BRCA

The Oncologist
Emily N RisdonWilliam D Figg

Sign up to follow this feed and discover related papers.

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Inflammatory Breast Neoplasms

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

© 2020 Meta ULC. All rights reserved
/feed-previews/breast-cancer-brca1-brca2/3a88eb04-0d5d-42e5-86ae-8af66af13fcb